Publications by authors named "Mu Xiuli"

Claim this Profile
5
5-Aza combined with VPA reprograms human T lineage acute leukemia Jurkat cells into B-cell-like cells by epigenetic activation of PAX5.
Wenjin Xi, Guoxu Zheng, Xu Chen, Baile Zuo, Wei Wang, Xiuli Mu

Biotechnol Prog· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of miR-124 enhances the therapeutic benefit of TMZ treatment in the orthotopic GBM mice model by inhibition of DNA damage repair.
Yuchen Wei, Peng Wang, Jianhui Zhao, Xin Fan, Jun Jiang, Xiuli Mu

Cell Death Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant activation of a miR-101-UBE2D1 axis contributes to the advanced progression and chemotherapy sensitivity in human hepatocellular carcinoma.
Xiuli Mu, Yuchen Wei, Xin Fan, Rui Zhang, Wenjin Xi

Cell Death Discov· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ponatinib inhibits the proliferation of SNU-449 human hepatocellular cancer cells and blocks MAPK and PDK1/AKT/mTOR signaling pathways].
Chang Liu, Jinhong Pei, Xiuli Mu, Baofeng Yu, Tao Gong

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Multi-target kinase inhibitor dasatinib inhibits cell proliferation, dissociation and migration via up-regulating E-cadherin expression in SK-Hep-1 human hepatocellular cancer cells].
Chang Liu, Jinhong Pei, Xiuli Mu, Baofeng Yu

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib inhibits proliferation of liver cancer cells, but activation of Akt/mTOR compromises dasatinib as a cancer drug.
Chang Liu, Xiaoxia Zhu, Yuqi Jia, Fenqing Chi, Keru Qin, Xiuli Mu

Acta Biochim Biophys Sin (Shanghai)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chidamide induces apoptosis in DLBCL cells by suppressing the HDACs/STAT3/Bcl‑2 pathway.
Hongwei Zhang, Fenqing Chi, Keru Qin, Xiuli Mu, Lieyang Wang

Mol Med Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma.
Chang Liu, Chaochao Wen, Xi Wang, Yan Wei, Chunyang Xu, Xiuli Mu

Exp Cell Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Ponatinib Inhibits Proliferation and Induces Apoptosis of Liver Cancer Cells, but Its Efficacy Is Compromised by Its Activation on PDK1/Akt/mTOR Signaling.
Chang Liu, Xiuli Mu, Xuan Wang, Chan Zhang, Lina Zhang

Molecules· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of regional myocardial stunning after exercise in gated myocardial SPECT.
Asit Kr Paul, Shinji Hasegawa, Jun Yoshioka, Xiuli Mu, Kaoru Maruyama

J Nucl Cardiol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET.
Atsushi Maruyama, Shinji Hasegawa, Asit Kr Paul, Mu Xiuli, Jun Yoshioka

Ann Nucl Med· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis